clinical trials

The Alzheimer's pipeline is as strong as ever. Now, we just need the patients
The Alzheimer's pipeline is as strong as ever. Now, we just need the patients
Fierce Biotech
Alzheimer's disease
patients
clinical trials
Biogen
Eisai
Eli Lilly
Flag link:
AbbVie's Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3
AbbVie's Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3
Fierce Pharma
AbbVie
Rinvoq
Humira
systemic lupus erythematosus
lupus
clinical trials
Flag link:
Rain Oncology to cut 65% of staff after milademetan Phase 3 trial failure
Rain Oncology to cut 65% of staff after milademetan Phase 3 trial failure
Medical Marketing and Media
Rain Oncology
layoffs
clinical trials
milademetan
oncology
solid tumors
Flag link:
Sanofi sees midphase success in multiple sclerosis decades after safety concerns scuttled peers
Sanofi sees midphase success in multiple sclerosis decades after safety concerns scuttled peers
Fierce Biotech
Sanofi
MS
multiple sclerosis
clinical trials
frexalimab
Flag link:
Pfizer's hemophilia drug hits in phase 3, giving it a chance to leapfrog Novo Nordisk
Pfizer's hemophilia drug hits in phase 3, giving it a chance to leapfrog Novo Nordisk
Fierce Biotech
Pfizer
Novo Nordisk
clinical trials
hemophilia
marstacimab
Flag link:
Xilio reports preliminary data from Phase I solid tumors therapy trial
Xilio reports preliminary data from Phase I solid tumors therapy trial
Clinical Trials Arena
Xilio Therapeutics
clinical trials
solid tumors
XTX101
Flag link:
AstraZeneca reports positive results from endometrial cancer therapy trial
AstraZeneca reports positive results from endometrial cancer therapy trial
Clinical Trials Arena
AstraZeneca
endometrial cancer
clinical trials
Imfinzi
Lynparza
Flag link:
Elon Musk’s Neuralink clears FDA hurdle, gears up for human trials
Elon Musk’s Neuralink clears FDA hurdle, gears up for human trials
Medical Marketing and Media
Neuralink
FDA
clinical trials
brain implants
Elon Musk
Flag link:
ASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a single-arm trial persuade the FDA?
ASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a single-arm trial persuade the FDA?
Fierce Pharma
ASCO 2023
Bristol Myers Squibb
Breyanzi
CAR-T
CLL
SLL
clinical trials
Flag link:
Topas launches Phase IIa trial of celiac disease therapy
Topas launches Phase IIa trial of celiac disease therapy
Clinical Trials Arena
Topas Therapeutics
clinical trials
celiac disease
TPM502
Flag link:
Bristol Myers data make case for earlier use of bone marrow disease drug
Bristol Myers data make case for earlier use of bone marrow disease drug
BioPharma Dive
Bristol Myers Squibb
Reblozyl
Epogen
myelodysplastic syndromes
clinical trials
Flag link:
Annexon reports topline results from Phase II trial of geographic atrophy therapy
Annexon reports topline results from Phase II trial of geographic atrophy therapy
Clinical Trials Arena
Annexon
clinical trials
ANX007
vision loss
geographic atrophy
Flag link:
Apellis abandons ALS drug after study miss
Apellis abandons ALS drug after study miss
BioPharma Dive
Apellis Pharmaceuticals
ALS
clinical trials
pegcetacoplan
Flag link:
Mirati's long wait for next lung cancer med ends in phase 3 failure
Mirati's long wait for next lung cancer med ends in phase 3 failure
Fierce Biotech
Mirati Therapeutics
clinical trials
sitravantinib
lung cancer
non small cell lung cancer
Flag link:
PTC Cuts Early-Stage Pipeline but Pushes Forward on FA Drug After Phase III Flop
PTC Cuts Early-Stage Pipeline but Pushes Forward on FA Drug After Phase III Flop
BioSpace
PTC Therapeutics
Friedreich's Ataxia
clinical trials
vatiquinone
Flag link:
Why Is CVS Health Clinical Trial Services Closing?
Why Is CVS Health Clinical Trial Services Closing?
Xtalks
CVS Health
clinical trials
Flag link:
Rain Oncology Plummets after Lead Candidate Disappoints in Phase 3
Rain Oncology Plummets after Lead Candidate Disappoints in Phase 3
Tip Ranks
Rain Oncology
liposarcoma
clinical trials
milademetan
Flag link:
Bristol Myers Squibb eyes phase 3 after pulmonary fibrosis drug reduces lung function decline
Bristol Myers Squibb eyes phase 3 after pulmonary fibrosis drug reduces lung function decline
Fierce Biotech
Bristol Myers Squibb
clinical trials
BMS-986278
idiopathic pulmonary fibrosis
Flag link:
Wave's ALS-dementia drug crashes out after early-phase flop, dealing further blow to target
Wave's ALS-dementia drug crashes out after early-phase flop, dealing further blow to target
Fierce Biotech
Wave Life Sciences
antisense
WVE-004
clinical trials
ALS
dementia
Flag link:
Roche Terminates Second Phase II Schizophrenia Trial
Roche Terminates Second Phase II Schizophrenia Trial
BioSpace
Roche
schizophrenia
ralmitaront
clinical trials
Flag link:

Pages